Literature DB >> 14597790

Diffuse large B cell lymphoma in a patient with hypocomplementemic urticarial vasculitis.

J M Calvo-Romero1.   

Abstract

Hypocomplementemic urticarial vasculitis (HUV) is known to be associated with malignancies. Urticarial vasculitis has been linked to lymphomas, but to our knowledge, the association of HUV and non-Hodgkin lymphoma has not been described so far. A patient with HUV who developed 10 years later a diffuse large B cell lymphoma is reported here.

Entities:  

Mesh：

Year:  2003        PMID： 14597790

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN： 0022-3859            Impact factor:   1.476


  5 in total

1.  Hypocomplementemic urticarial vasculitis syndrome: a case report and literature review.

Authors:  Andrew Buck; Jim Christensen; Morgan McCarty
Journal:  J Clin Aesthet Dermatol       Date:  2012-01

2.  Cutaneous vasculitis as an initiating paraneoplastic symptom in Hodgkin lymphoma.

Authors:  Zsófia Simon; Tünde Tarr; László Tóth; Gabriella Szucs; Arpád Illés
Journal:  Rheumatol Int       Date:  2007-12-19       Impact factor: 2.631

Review 3.  Exceptional association of hypocomplementemic urticarial vasculitis syndrome (HUVS) and symptomatic pulmonary histoplasmosis: a case-based literature review.

Authors:  Mohammad Alomari; Laith Al Momani; Shrouq Khazaaleh; Shaden Almomani; Kinanah Yaseen; Bassam Alhaddad
Journal:  Clin Rheumatol       Date:  2019-04-13       Impact factor: 3.650

Review 4.  Hypocomplementemic urticarial vasculitis syndrome.

Authors:  Luis J Jara; Carmen Navarro; Gabriela Medina; Olga Vera-Lastra; Miguel A Saavedra
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.686

5.  Urticarial vasculitis in northern Spain: clinical study of 21 cases.

Authors:  Javier Loricera; Vanesa Calvo-Río; Cristina Mata; Francisco Ortiz-Sanjuán; Marcos A González-López; Lino Alvarez; M Carmen González-Vela; Susana Armesto; Héctor Fernández-Llaca; Javier Rueda-Gotor; Miguel A González-Gay; Ricardo Blanco
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.